Endo International (ENDP) Dropped After FDA Requested Removal Of Opana

The FDA asked Endo International (ENDP) to remove Opana ER, its opioid pain medication, from the market late Thursday. The FDA is concerned that the benefits of the drug may no longer outweigh its risks.

from RTT - Before the Bell http://ift.tt/2sejkiZ
via IFTTT